Table. Laboratory findings for patient with human granulocytic anaplasmosis, South Korea, 2013*.
| Laboratory test (reference range) | Day 5† | Day 6 | Day 7 | Day 8 | Day 9 | Day 10 | Day 11 | Day 19‡ |
|---|---|---|---|---|---|---|---|---|
| Leukocytes, cells/μL (3,800–10,000) | 2,400 | 1,100 | 7,400 | 5,800 | 5,200 | 5,700 | 4,800 | 5,700 |
| Neutrophils, % (40–70) | 91 | 28 | 79 | 62 | 50 | 42 | 39 | 51 |
| Lymphocytes, % (20–50) | 7 | 64 | 17 | 31 | 39 | 45 | 47 | 42 |
| Hb, g/dL (12.3–15.3) | 9.4 | 9.3 | 9.4 | 8.7 | 8.8 | 10.4 | 9.8 | 10.3 |
| Hct, % (36.6–44.2) | 28.5 | 27.3 | 28.8 | 26.4 | 27.4 | 32.5 | 30.5 | 31.0 |
| Platelets/μL (140,000–400,000) | 78,000 | 61,000 | 63,000 | 69,000 | 105,000 | 194,000 | 249,000 | 348,000 |
| AST, IU/L (15–41) | 137 | 179 | 80 | 48 | 106 | 111 | 64 | 25 |
| ALT, IU/L (14–54) | 60 | 93 | 73 | 55 | 84 | 105 | 83 | 26 |
| CPK, IU/L (38–234) | 74 | 156 | 148 | 64 | 41 | 31 | NA | 39 |
| LDH, IU/L (100–190) | 280 | 384 | 275 | 203 | 243 | 239 | 180 | 134 |
| Creatinine, mg/dL (0.4–1.0) | 0.8 | 0.7 | 0.5 | 0.5 | 0.5 | 0.7 | NA | 0.6 |
| C-reactive protein, mg/dL (0–0.50) | 6.11 | 7.04 | NA | NA | NA | NA | 0.62 | NA |
| PT, INR (0.92–1.17) | 1.05 | 1.17 | 1.00 | 0.97 | NA | NA | NA | NA |
| aPTT, s (31.0–43.7) | 44.8 | 57.6 | 49.3 | 41.5 | NA | NA | NA | NA |
| Fibrinogen, mg/dL (207–408) | NA | 304 | 328 | 308 | NA | NA | NA | NA |
*Day 0 was day of illness onset. Hb, hemoglobin; Hct, hematocrit; AST, aspartate aminotransferase; ALT, alanine aminotransferase; CPK, creatine phosphokinase; NA, not available; LDH, lactate dehydrogenase; PT, prothrombin time; INR, international normalized ratio; aPTT, activated partial thromboplastin time. †Blood samples for culture and for immunofluorescence antibody test were obtained. ‡Blood samples for immunofluorescence antibody test were obtained.